Ameritas Advisory Services LLC Trims Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Ameritas Advisory Services LLC trimmed its holdings in The Procter & Gamble Company (NYSE:PG) by 18.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,242 shares of the company’s stock after selling 8,553 shares during the period. Ameritas Advisory Services LLC’s holdings in Procter & Gamble were worth $6,450,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $29,000. Ruedi Wealth Management Inc. lifted its holdings in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the last quarter. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $34,000. Finally, Quest Partners LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $36,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Procter & Gamble

In other news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at $6,325,360. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 385,771 shares of company stock worth $65,610,975. Insiders own 0.18% of the company’s stock.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock traded down $0.31 on Tuesday, hitting $164.77. 252,868 shares of the company’s stock were exchanged, compared to its average volume of 6,609,407. The company has a 50-day simple moving average of $171.52 and a 200-day simple moving average of $168.13. The stock has a market capitalization of $388.04 billion, a PE ratio of 28.46, a PEG ratio of 3.57 and a beta of 0.42. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s revenue was down .6% compared to the same quarter last year. During the same quarter last year, the company posted $1.83 EPS. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.44%. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Analyst Upgrades and Downgrades

PG has been the subject of several recent research reports. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. TD Cowen assumed coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. Morgan Stanley boosted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Finally, Jefferies Financial Group cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and decreased their price objective for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.